MEIP MEI PHARMA INC Business Restructuring 8-K Filing 2024 - Evaluation of Strategic Alternatives and Departure of Executives MEI Pharma, Inc. announced the evaluation of strategic alternatives, including potential transactions and a possible wind-down of the company, and the departure of its President and Chief Medical Officer.Get access to all SEC 8-K filings of the MEI PHARMA INC